Business Description
Third Harmonic Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US88427A1079
Description
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 87.01 | |||||
| Equity-to-Asset | 0.97 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -37.8 | |||||
| 3-Year EPS without NRI Growth Rate | -30.9 | |||||
| 3-Year FCF Growth Rate | -14.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -37.76 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.7 | |||||
| 9-Day RSI | 52.64 | |||||
| 14-Day RSI | 50.79 | |||||
| 6-1 Month Momentum % | -6 | |||||
| 12-1 Month Momentum % | 70.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 42.5 | |||||
| Quick Ratio | 42.5 | |||||
| Cash Ratio | 41.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.9 | |||||
| Shareholder Yield % | 0.11 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -14.44 | |||||
| ROA % | -13.99 | |||||
| ROIC % | -692.36 | |||||
| ROC (Joel Greenblatt) % | -1386.75 | |||||
| ROCE % | -19.25 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.96 | |||||
| Price-to-Tangible-Book | 1.99 | |||||
| EV-to-EBIT | -5.49 | |||||
| EV-to-EBITDA | -5.49 | |||||
| EV-to-FCF | -10.04 | |||||
| Price-to-Net-Current-Asset-Value | 2.02 | |||||
| Price-to-Net-Cash | 2.05 | |||||
| Earnings Yield (Greenblatt) % | -18.21 | |||||
| FCF Yield % | -4.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:THRD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Third Harmonic Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.96 | ||
| Beta | 0 | ||
| Volatility % | 57.62 | ||
| 14-Day RSI | 50.79 | ||
| 14-Day ATR ($) | 1.146296 | ||
| 20-Day SMA ($) | 13.12775 | ||
| 12-1 Month Momentum % | 70.12 | ||
| 52-Week Range ($) | 7.65 - 16.94 | ||
| Shares Outstanding (Mil) | 45.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Third Harmonic Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Third Harmonic Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Third Harmonic Bio Inc Frequently Asked Questions
What is Third Harmonic Bio Inc(THRD)'s stock price today?
The current price of THRD is $13.11. The 52 week high of THRD is $16.94 and 52 week low is $7.65.
When is next earnings date of Third Harmonic Bio Inc(THRD)?
The next earnings date of Third Harmonic Bio Inc(THRD) is 2025-03-26 Est..
Does Third Harmonic Bio Inc(THRD) pay dividends? If so, how much?
Third Harmonic Bio Inc(THRD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers